title: Von Willebrand Factor--A New Target for TTP Treatment?
authors: From the Hematology Department and Research Unit EA3518, Institute of Hematology, French Reference Center for Thrombotic Microangiopathies, Hospital Group Saint Louis-Lariboisière-Fernand Widal, Assistance Publique-Hôpitaux de Paris, University Paris Diderot, Paris.
authors: Agnès
authors: A
authors: Veyradier
mesh_terms: D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011697:Purpura, Thrombotic Thrombocytopenic / Q000188:drug therapy*; D061905:Single-Domain Antibodies / Q000627:therapeutic use*; D014841:von Willebrand Factor / Q000037:antagonists & inhibitors*
chemical_list: D005343:Fibrinolytic Agents; D061905:Single-Domain Antibodies; D014841:von Willebrand Factor; C585343:caplacizumab